Concepedia

Donald W. Combs

DW

Statistics

Publications

23

Citations

806

H-Index

18

Active since

1980

Affiliations

Johnson & Johnson (United States)(Current)

Bristol-Myers Squibb (United States)

Bristol-Myers Squibb (Sweden)

Bristol-Myers Squibb (Germany)

Donald W. Combs is an author at Johnson & Johnson (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1980–2011

23

Publications

23

6-Benzoxazinylpyridazin-3-ones: potent, long-acting positive inotrope and peripheral vasodilator agents

Donald W. Combs, M. S. RAMPULLA, Stanley C. Bell et al. · Journal of Medicinal Chemistry · 1990 · 97 citations · Full text

, , +7

Nonsteroidal progesterone receptor ligands. 1. 3-Aryl-1-benzoyl-1,4,5,6- tetrahydropyridazines.

Donald W. Combs, Kimberly Reese, A. Phillips · Journal of Medicinal Chemistry · 1995 · 73 citations · Full text

, , +9

Therapeutic Activity of Pretazettine on Rauscher Leukemia: Comparison with the Related Amaryllidaceae Alkaloids

Eiichi Furusawa, Hiroshi Irie, Donald W. Combs et al. · Chemotherapy · 2009 · 58 citations

, , +11

Nonsteroidal Progesterone Receptor Ligands. 2. High-Affinity Ligands with Selectivity for Bone Cell Progesterone Receptors

Donald W. Combs, Kimberly Reese, Lyndon A. M. Cornelius et al. · Journal of Medicinal Chemistry · 1995 · 54 citations · Full text

, , +13

Discovery of selective imidazole-based inhibitors of mammalian 15-lipoxygenase: Highly potent against human enzyme within a cellular environment

David S. Weinstein, Wen Liu, Khehyong Ngu et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 53 citations · Full text

, , +10

1–5 of 23